Oncologic considerations in nonmelanotic skin cancer.
Although excision of nonmelanotic skin cancer carries a high cure rate, a potential exists in a small percentage of patients for not only significant morbidity, but mortality as well. Some prognostic variables and clinical guidelines have been developed that can be applied to individual patients.
Luce
E A
EA
Department of Surgery, University of Kentucky Chandler Medical Center, Lexington, USA.
D000328:Adult; D002280:Basal Cell Carcinoma / Q000235:genetics / Q000556:secondary / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000556:secondary / Q000628:therapy*; D003131:Combined Modality Therapy; D004273:DNA, Neoplasm / Q000032:analysis; D006801:Humans; D008297:Male; D015580:Mohs Surgery; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000628:therapy*; D011230:Precancerous Conditions; D018714:Radiotherapy, Adjuvant; D012878:Skin Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy*
D004273:DNA, Neoplasm